Galmed Pharmaceuticals Ltd. (GLMD) › Shareholders' EquityGalmed Pharmaceuticals Ltd. (GLMD) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2011: -$2.71M2012: -$1.98M2013: -$1.95M2014: $31.41M2015: $21.55M2016: $11.07M2017: $15.79M2018: $87.89M2019: $69.85M2020: $44.15M2021: $30.50M2022: $13.42M2023: $13.88M2024: $16.33M2025: $15.78M$15.78M2011Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$15.78M-3.3%2024$16.33M+17.6%2023$13.88M+3.4%2022$13.42M-56.0%2021$30.50M-30.9%2020$44.15M-36.8%2019$69.85M-20.5%2018$87.89M+456.5%2017$15.79M+42.6%2016$11.07M-48.6%2015$21.55M-31.4%2014$31.41M+1709.8%2013-$1.95M+1.4%2012-$1.98M+27.0%2011-$2.71M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share